Previous Close | 0.5500 |
Open | 0.7500 |
Bid | 0.1500 |
Ask | 1.4000 |
Strike | 17.50 |
Expire Date | 2024-05-17 |
Day's Range | 0.5500 - 0.7500 |
Contract Range | N/A |
Volume | |
Open Interest | 40 |
REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Wednesday, May 8, 2024, at 4:30 p.m. ET to discuss its financial results for the first quarter ended March 31, 2024, and recent operational highlights.
REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit on Monday, April 29, 2024.
Key Insights Significantly high institutional ownership implies REGENXBIO's stock price is sensitive to their trading...